JP2020506715A5 - - Google Patents

Download PDF

Info

Publication number
JP2020506715A5
JP2020506715A5 JP2019543805A JP2019543805A JP2020506715A5 JP 2020506715 A5 JP2020506715 A5 JP 2020506715A5 JP 2019543805 A JP2019543805 A JP 2019543805A JP 2019543805 A JP2019543805 A JP 2019543805A JP 2020506715 A5 JP2020506715 A5 JP 2020506715A5
Authority
JP
Japan
Prior art keywords
seq
sequence shown
specific binding
amino acid
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019543805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506715A (ja
JP7189142B2 (ja
Filing date
Publication date
Priority claimed from GBGB1702091.8A external-priority patent/GB201702091D0/en
Application filed filed Critical
Publication of JP2020506715A publication Critical patent/JP2020506715A/ja
Publication of JP2020506715A5 publication Critical patent/JP2020506715A5/ja
Application granted granted Critical
Publication of JP7189142B2 publication Critical patent/JP7189142B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019543805A 2017-02-08 2018-02-08 抗ヒトアネキシンa1抗体 Active JP7189142B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1702091.8A GB201702091D0 (en) 2017-02-08 2017-02-08 Specific binding molecules
GB1702091.8 2017-02-08
PCT/EP2018/053232 WO2018146230A1 (en) 2017-02-08 2018-02-08 Anti human annexin a1 antibody

Publications (3)

Publication Number Publication Date
JP2020506715A JP2020506715A (ja) 2020-03-05
JP2020506715A5 true JP2020506715A5 (enExample) 2021-03-18
JP7189142B2 JP7189142B2 (ja) 2022-12-13

Family

ID=58462456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019543805A Active JP7189142B2 (ja) 2017-02-08 2018-02-08 抗ヒトアネキシンa1抗体

Country Status (14)

Country Link
US (1) US11041019B2 (enExample)
EP (1) EP3579875B1 (enExample)
JP (1) JP7189142B2 (enExample)
KR (1) KR102687512B1 (enExample)
CN (1) CN110475570B (enExample)
AU (1) AU2018219595B2 (enExample)
BR (1) BR112019016160A2 (enExample)
CA (1) CA3052903C (enExample)
ES (1) ES3009440T3 (enExample)
GB (1) GB201702091D0 (enExample)
IL (1) IL268506A (enExample)
MX (1) MX2019009382A (enExample)
RU (1) RU2019126888A (enExample)
WO (1) WO2018146230A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103097414B (zh) 2010-06-09 2016-05-18 伦敦大学玛丽皇后和威斯特-弗尔德学院 膜联蛋白1抗体
GB201121564D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
US11326182B2 (en) 2016-04-29 2022-05-10 Voyager Therapeutics, Inc. Compositions for the treatment of disease
EP3448987A4 (en) 2016-04-29 2020-05-27 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
GB201813137D0 (en) 2018-08-10 2018-09-26 Medannex Ltd Cancer treatment with an antibody
US12134655B2 (en) 2019-04-30 2024-11-05 Absci Corporation Cancer associated antibody compositions and methods of use
EP4061420A1 (en) * 2019-11-20 2022-09-28 Abvision, Inc. Monoclonal antibodies that target human cd47 protein
CN112898414B (zh) * 2019-12-04 2024-05-10 珠海泰诺麦博制药股份有限公司 抗人巨细胞病毒抗体及其用途
US20240124606A1 (en) * 2021-02-22 2024-04-18 Northwestern University Anti-cd73 monoclonal antibodies
EP4433171A1 (en) 2021-11-18 2024-09-25 Medannex Ltd. Combination therapy for cancer
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625941D0 (en) 1986-10-30 1986-12-03 Sandoz Ltd Substituted alpha-amino acids
US5051364A (en) 1989-02-16 1991-09-24 The Salk Institute For Biological Studies Anti-lipocortin-I and anti-lipocortin-II monoclonal antibodies
US5565338A (en) 1990-06-04 1996-10-15 La Jolla Institute For Allergy And Immunology Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US20050118688A1 (en) 2001-12-28 2005-06-02 Hudson Freeze Novel ligand involved in the transmigration of leukocytes across the endothelium and uses therefor
WO2005019429A2 (en) 2003-08-22 2005-03-03 Potentia Pharmaceuticals, Inc. Compositions and methods for enhancing phagocytosis or phagocyte activity
WO2005027965A1 (en) 2003-09-24 2005-03-31 Peter Krammer Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis.
EP1693385A4 (en) * 2003-11-11 2009-11-04 Chugai Pharmaceutical Co Ltd ANTI-CD47 ANTIBODIES HUMANIZED
AU2005249541B2 (en) 2004-06-02 2010-02-25 Jan E. Schnitzer Vascular targets for detecting, imaging and treating neoplasia or neovasculature
GB0822011D0 (en) 2008-12-02 2009-01-07 Queen Mary & Westfield College Treatment
CN103097414B (zh) * 2010-06-09 2016-05-18 伦敦大学玛丽皇后和威斯特-弗尔德学院 膜联蛋白1抗体
CN102898527B (zh) 2011-07-25 2016-12-21 三星电子株式会社 融合蛋白、药物组合物及预防或治疗癌症的方法
GB201121561D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Transgenic animal
GB201121564D0 (en) * 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
KR20150029457A (ko) 2013-09-10 2015-03-18 삼성전자주식회사 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도

Similar Documents

Publication Publication Date Title
JP2020506715A5 (enExample)
RU2019126888A (ru) Антитело к человеческому аннексину а1
JP2020023523A5 (enExample)
RU2495050C2 (ru) Связующий элемент для рецептора gm-csf
CN109311974A (zh) 抗人白细胞介素-17a单克隆抗体、其制备方法和应用
JP2010500876A5 (enExample)
ES2822431T3 (es) Polipéptidos de unión a IL-17A
Konwarh Nanobodies: prospects of expanding the gamut of neutralizing antibodies against the novel coronavirus, SARS-CoV-2
JP2016524463A5 (enExample)
RU2012118636A (ru) Молекула, специфически связывающаяся с rsv
JP2017522903A5 (enExample)
RU2016151265A (ru) Антитела, направленные на cd127
TW201326205A (zh) 具有人類ox40專一性之抗體分子
JP2014509510A5 (enExample)
JP2010502207A5 (enExample)
JP2014508511A5 (enExample)
TW201233795A (en) Chemokine receptor binding polypeptides
JP2008527989A5 (enExample)
JP2019521647A5 (enExample)
CN103497253A (zh) 一种针对h2a.z变体的纳米抗体、其编码序列及应用
JP2013531991A5 (enExample)
CN109897107B (zh) 纳米抗体及其制备方法
JP2014529398A5 (enExample)
CN110483640B (zh) 白介素-6r的人源化单克隆抗体、其编码基因及应用
CN102276722A (zh) 新型血管内皮生长因子人源化单克隆抗体